KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to 0.62.

  • Biogen's Equity Ratio rose 406.0% to 0.62 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.62, marking a year-over-year increase of 406.0%. This contributed to the annual value of 0.62 for FY2025, which is 406.0% up from last year.
  • According to the latest figures from Q4 2025, Biogen's Equity Ratio is 0.62, which was up 406.0% from 0.62 recorded in Q3 2025.
  • Biogen's Equity Ratio's 5-year high stood at 0.62 during Q3 2025, with a 5-year trough of 0.45 in Q1 2021.
  • For the 5-year period, Biogen's Equity Ratio averaged around 0.54, with its median value being 0.56 (2023).
  • As far as peak fluctuations go, Biogen's Equity Ratio crashed by 687.14% in 2021, and later surged by 2152.64% in 2023.
  • Quarter analysis of 5 years shows Biogen's Equity Ratio stood at 0.46 in 2021, then increased by 18.79% to 0.55 in 2022, then grew by 1.11% to 0.55 in 2023, then rose by 8.1% to 0.6 in 2024, then increased by 4.06% to 0.62 in 2025.
  • Its Equity Ratio was 0.62 in Q4 2025, compared to 0.62 in Q3 2025 and 0.62 in Q2 2025.